Lv W, Wang Y
CNS Neurosci Ther. 2024; 30(10):e70097.
PMID: 39469896
PMC: 11519750.
DOI: 10.1111/cns.70097.
Yuzhalin A, Lowery F, Saito Y, Yuan X, Yao J, Duan Y
Nat Cell Biol. 2024; 26(10):1773-1789.
PMID: 39304713
PMC: 11676029.
DOI: 10.1038/s41556-024-01509-5.
Kumar U
Int J Mol Sci. 2024; 25(1).
PMID: 38203605
PMC: 10779198.
DOI: 10.3390/ijms25010436.
Samuels M, Jones W, Towler B, Turner C, Robinson S, Giamas G
Oncogene. 2023; 42(41):3017-3034.
PMID: 37670020
PMC: 10555829.
DOI: 10.1038/s41388-023-02827-y.
Sanchez-Aguilera A, Masmudi-Martin M, Navas-Olive A, Baena P, Hernandez-Oliver C, Priego N
Cancer Cell. 2023; 41(9):1637-1649.e11.
PMID: 37652007
PMC: 10507426.
DOI: 10.1016/j.ccell.2023.07.010.
Leveraging translational insights toward precision medicine approaches for brain metastases.
Kim A, Nieblas-Bedolla E, de Sauvage M, Brastianos P
Nat Cancer. 2023; 4(7):955-967.
PMID: 37491527
PMC: 10644911.
DOI: 10.1038/s43018-023-00585-0.
Clonogenicity-based radioresistance determines the expression of immune suppressive immune checkpoint molecules after hypofractionated irradiation of MDA-MB-231 triple-negative breast cancer cells.
Gehre S, Meyer F, Sengedorj A, Grottker F, Reichardt C, Alomo J
Front Oncol. 2023; 13:981239.
PMID: 37152024
PMC: 10157086.
DOI: 10.3389/fonc.2023.981239.
Reprogramming anchorage dependency by adherent-to-suspension transition promotes metastatic dissemination.
Huh H, Sub Y, Oh J, Kim Y, Lee J, Kim H
Mol Cancer. 2023; 22(1):63.
PMID: 36991428
PMC: 10061822.
DOI: 10.1186/s12943-023-01753-7.
Brain metastasis in breast cancer: focus on genes and signaling pathways involved, blood-brain barrier and treatment strategies.
Chhichholiya Y, Ruthuparna M, Velagaleti H, Munshi A
Clin Transl Oncol. 2023; 25(5):1218-1241.
PMID: 36897508
DOI: 10.1007/s12094-022-03050-z.
An HLA-G/SPAG9/STAT3 axis promotes brain metastases.
Bassey-Archibong B, Rajendra Chokshi C, Aghaei N, Kieliszek A, Tatari N, McKenna D
Proc Natl Acad Sci U S A. 2023; 120(8):e2205247120.
PMID: 36780531
PMC: 9974476.
DOI: 10.1073/pnas.2205247120.
Tumor microenvironment and exosomes in brain metastasis: Molecular mechanisms and clinical application.
Aili Y, Maimaitiming N, Qin H, Ji W, Fan G, Wang Z
Front Oncol. 2022; 12:983878.
PMID: 36338717
PMC: 9631487.
DOI: 10.3389/fonc.2022.983878.
A distinct pattern of growth and RAC1 signaling in melanoma brain metastasis cells.
Stejerean-Todoran I, Gimotty P, Watters A, Brafford P, Krepler C, Godok T
Neuro Oncol. 2022; 25(4):674-686.
PMID: 36054930
PMC: 10076948.
DOI: 10.1093/neuonc/noac212.
Identifying Topics and Evolutionary Trends of Literature on Brain Metastases Using Latent Dirichlet Allocation.
Chen J, Williams M, Huang Y, Si S
Front Mol Biosci. 2022; 9:858577.
PMID: 35720132
PMC: 9201447.
DOI: 10.3389/fmolb.2022.858577.
Evaluation of the TRIP13 level in breast cancer and insights into potential molecular pathways.
Lan J, Huang J, Tao X, Gao Y, Zhang L, Huang W
J Cell Mol Med. 2022; 26(9):2673-2685.
PMID: 35322916
PMC: 9077308.
DOI: 10.1111/jcmm.17278.
A clinically compatible drug-screening platform based on organotypic cultures identifies vulnerabilities to prevent and treat brain metastasis.
Zhu L, Retana D, Garcia-Gomez P, Alvaro-Espinosa L, Priego N, Masmudi-Martin M
EMBO Mol Med. 2022; 14(3):e14552.
PMID: 35174975
PMC: 8899920.
DOI: 10.15252/emmm.202114552.
Functional Genomic Analysis of Breast Cancer Metastasis: Implications for Diagnosis and Therapy.
Yu Z, Song M, Chouchane L, Ma X
Cancers (Basel). 2021; 13(13).
PMID: 34208889
PMC: 8268362.
DOI: 10.3390/cancers13133276.
Novel Gene Signatures Predictive of Patient Recurrence-Free Survival and Castration Resistance in Prostate Cancer.
A J, Zhang B, Zhang Z, Hu H, Dong J
Cancers (Basel). 2021; 13(4).
PMID: 33671634
PMC: 7927111.
DOI: 10.3390/cancers13040917.
Advances in Lung Cancer Driver Genes Associated With Brain Metastasis.
Kang Y, Jin Y, Li Q, Yuan X
Front Oncol. 2021; 10:606300.
PMID: 33537237
PMC: 7848146.
DOI: 10.3389/fonc.2020.606300.
"Triple-Negative Breast Cancer Central Nervous System Metastases From the Laboratory to the Clinic".
Zimmer A
Cancer J. 2021; 27(1):76-82.
PMID: 33475296
PMC: 7839270.
DOI: 10.1097/PPO.0000000000000503.
Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts.
Woo X, Giordano J, Srivastava A, Zhao Z, Lloyd M, de Bruijn R
Nat Genet. 2021; 53(1):86-99.
PMID: 33414553
PMC: 7808565.
DOI: 10.1038/s41588-020-00750-6.